JP Morgan Chase’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.3K Buy
+825
New +$12.7K ﹤0.01% 6841
2025
Q2
Sell
-277
Closed -$3.99K 7075
2025
Q1
$3.99K Buy
277
+268
+2,978% +$4.09K ﹤0.01% 6462
2024
Q4
$136 Sell
9
-141
-94% -$2.27K ﹤0.01% 6963
2024
Q3
$2.47K Sell
150
-33
-18% -$541 ﹤0.01% 6593
2024
Q2
$3K Sell
183
-100
-35% -$1.61K ﹤0.01% 6466
2024
Q1
$4.72K Buy
+283
New +$4.39K ﹤0.01% 6464
2023
Q3
Sell
-95
Closed -$1.45K 7461
2023
Q2
$1.45K Sell
95
-110,149
-100% -$1.65M ﹤0.01% 6399
2023
Q1
$1.67M Buy
110,244
+72,968
+196% +$1.08M ﹤0.01% 3666
2022
Q4
$517K Buy
+37,276
New +$526K ﹤0.01% 4485

Other funds holding BCAT

JP Morgan Chase's BCAT Position: Q2 2026 in Review

JP Morgan Chase opened a new position in BlackRock Capital Allocation Term Trust (BCAT) in Q2 2026: 825 shares worth $13.3K. The stake represents ﹤0.01% of the portfolio and ranks #6841 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in BCAT as recently as Q1 2025.

JP Morgan Chase first reported a position in BCAT in Q4 2022 and has held it in 9 quarters since. The position peaked at $1.67M in Q1 2023. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.

  • JP Morgan Chase held 825 shares of BlackRock Capital Allocation Term Trust worth $13.3K as of Q2 2026.
  • BlackRock Capital Allocation Term Trust was a new JP Morgan Chase position in Q2 2026.
  • BlackRock Capital Allocation Term Trust made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6841 holding.
  • JP Morgan Chase first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and has held it in 9 quarters since.
  • JP Morgan Chase's BlackRock Capital Allocation Term Trust position peaked at $1.67M in Q1 2023.
  • 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.